Release Date: 25/02/19 15:56 Summary: H1 FY19 Results Release Cover Note Price Sensitive: No Download Document 33.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%